Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Basile

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Journal of the American Society of Hypertension : JASH|April 20, 2010
Combination therapy in hypertensionAlan H Gradman, Jan N Basile, Barry L Carter, et al.
Bioorganic & Medicinal Chemistry|November 13, 2022
Phenolic furanochromene hydrazone derivatives: Synthesis, antioxidant activity, ferroptosis inhibition, DNA cleavage and DNA molecular docking studiesJessica L Saylor, Olivia N Basile, Huifang Li, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 2017
Hypertension and Its Complications in a Young Man With Autoimmune DiseaseEve Miller-Hodges, Anna F Dominiczak, Garry L R Jennings, et al.
Journal of Molecular Recognition : JMR|March 2, 2011
Interaction map of the Trypanosoma cruzi ribosomal P protein complex (stalk) and the elongation factor 2Cristian R Smulski, Silvia A Longhi, Maximiliano Juri Ayub, et al.
Quality & Safety in Health Care|August 4, 2005
A trial of education, prompts, and opinion leaders to improve prescription of lipid modifying therapy by primary care physicians for patients with ischemic heart diseaseH E Bloomfield, D B Nelson, M van Ryn, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 10, 2016
Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH SubstudyMichael A Weber, Michael Bloch, George L Bakris, et al.
The American Journal of Cardiology|July 12, 2007
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialWilliam C Cushman, Richard H Grimm, Jeffrey A Cutler, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2004
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT studyJoshua I Barzilay, Barry R Davis, Judy Bettencourt, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 5, 2008
Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Mahboob Rahman, Charles Baimbridge, Barry R Davis, et al.
Clinical Nephrology|July 3, 2013
Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHATMahboob Rahman, Charles Baimbridge, Barry R Davis, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Journal of the American Society of Hypertension : JASH|April 20, 2010
Combination therapy in hypertensionAlan H Gradman, Jan N Basile, Barry L Carter, et al.
Bioorganic & Medicinal Chemistry|November 13, 2022
Phenolic furanochromene hydrazone derivatives: Synthesis, antioxidant activity, ferroptosis inhibition, DNA cleavage and DNA molecular docking studiesJessica L Saylor, Olivia N Basile, Huifang Li, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 2017
Hypertension and Its Complications in a Young Man With Autoimmune DiseaseEve Miller-Hodges, Anna F Dominiczak, Garry L R Jennings, et al.
Journal of Molecular Recognition : JMR|March 2, 2011
Interaction map of the Trypanosoma cruzi ribosomal P protein complex (stalk) and the elongation factor 2Cristian R Smulski, Silvia A Longhi, Maximiliano Juri Ayub, et al.
Quality & Safety in Health Care|August 4, 2005
A trial of education, prompts, and opinion leaders to improve prescription of lipid modifying therapy by primary care physicians for patients with ischemic heart diseaseH E Bloomfield, D B Nelson, M van Ryn, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 10, 2016
Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH SubstudyMichael A Weber, Michael Bloch, George L Bakris, et al.
The American Journal of Cardiology|July 12, 2007
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialWilliam C Cushman, Richard H Grimm, Jeffrey A Cutler, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2004
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT studyJoshua I Barzilay, Barry R Davis, Judy Bettencourt, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 5, 2008
Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Mahboob Rahman, Charles Baimbridge, Barry R Davis, et al.
Clinical Nephrology|July 3, 2013
Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHATMahboob Rahman, Charles Baimbridge, Barry R Davis, et al.
Pageof 13